QNRXNasdaqPharmaceutical Preparations
Quoin Pharmaceuticals Ltd.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$3.98+0.08 (+2.05%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Quoin Pharmaceuticals has not reported a dividend
No dividend per share appears in Quoin Pharmaceuticals's annual filings since fiscal 2015.